Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

helena laboratories australia pty ltd - ct827 - clinical chemistry enzyme ivds - reagents and kits intended for the qualitative, semi quantitative and quantitative separation of enzymes and their isoenzymes by electrophoresis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - ct833 - clinical chemistry substrate ivds - determination of haemoglobin a1c in human whole blood using ion-exchange high performance liquid chromatography (hplc).

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

helena laboratories australia pty ltd - ct833 - clinical chemistry substrate ivds - reagents and kits intended for the qualitative, semi-quantitative separation of cholesterol, lipids and lipoproteins.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - ct184 - clinical chemistry toxicology/drug detection ivds - ivds latheral flow chromatographic immunoassay that are intended to be used for the qualitative determination of toxic substances, pharmaceutical drugs and/or drugs of abuse in a clinical specimen

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

helena laboratories australia pty ltd - ct974 - clinical chemistry-specific protein ivds - reagents and kits intended to be used for gel electrophoresis and capillary electrophoresis for the separation of proteins.

Israel - anglès - Ministry of Health

rafa laboratories ltd - pralatrexate - solution for injection - pralatrexate 20 mg/ml - pralatrexate - pralatrexate - for the treatment of patients with relapsed or refractory peripheral t-cell lymphoma (ptcl).

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - carbamazepine - tablets - 200mg milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - carbamazepine - tablets - 400mg milligram

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - pseudoephedrine hydrochloride, quantity: 30 mg; dextromethorphan hydrobromide monohydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: carnauba wax; purified water; povidone; magnesium stearate; hydrogenated vegetable oil; croscarmellose sodium; microcrystalline cellulose; pregelatinised maize starch; sodium starch glycollate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - provides temporary relief of nagging cough and discomfort associated with cold and flu: relieves blocked noses, dries runny noses, provides temporary relief of cough and headache, relieves body aches and pains, reduces fever.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - paracetamol, quantity: 500 mg; pseudoephedrine hydrochloride, quantity: 30 mg; chlorphenamine maleate, quantity: 2 mg - tablet, film coated - excipient ingredients: hydrogenated vegetable oil; croscarmellose sodium; pregelatinised maize starch; carnauba wax; magnesium stearate; microcrystalline cellulose; povidone; titanium dioxide; indigo carmine; hyprolose; iron oxide red; iron oxide black - provides fast and effective relief from the symptoms of cold and flu. the non-drowsy day tablet temporarily relieves: blocked noses, runny noses, nagging cough, headaches, body aches and pains, and fever. the night tablet contains an antihistamine and temporarily relieves: blocked noses, headaches, body aches and pains, and fever.